| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-59 |
Sentence |
denotes |
Human noroviruses recognize sialyl Lewis x neoglycoprotein. |
| T1 |
0-59 |
Sentence |
denotes |
Human noroviruses recognize sialyl Lewis x neoglycoprotein. |
| T1 |
0-59 |
Sentence |
denotes |
Human noroviruses recognize sialyl Lewis x neoglycoprotein. |
| TextSentencer_T2 |
60-342 |
Sentence |
denotes |
The carbohydrate binding characteristics of a norovirus GII.3 (Chron1) and a GII.4 (Dijon) strain were investigated using virus-like particles (VLPs) and saliva samples from 81 individuals genotyped for FUT2 (secretor) and FUT3 (Lewis) and phenotyped for ABO and Lewis blood groups. |
| T2 |
60-342 |
Sentence |
denotes |
The carbohydrate binding characteristics of a norovirus GII.3 (Chron1) and a GII.4 (Dijon) strain were investigated using virus-like particles (VLPs) and saliva samples from 81 individuals genotyped for FUT2 (secretor) and FUT3 (Lewis) and phenotyped for ABO and Lewis blood groups. |
| T2 |
60-342 |
Sentence |
denotes |
The carbohydrate binding characteristics of a norovirus GII.3 (Chron1) and a GII.4 (Dijon) strain were investigated using virus-like particles (VLPs) and saliva samples from 81 individuals genotyped for FUT2 (secretor) and FUT3 (Lewis) and phenotyped for ABO and Lewis blood groups. |
| TextSentencer_T3 |
343-584 |
Sentence |
denotes |
The two VLPs showed a typical secretor-gene-dependent binding and bound significantly stronger to saliva from A, B, and AB than from O individuals (P < 0.0001 and P < 0.001) but did not bind to any samples from secretor-negative individuals. |
| T3 |
343-584 |
Sentence |
denotes |
The two VLPs showed a typical secretor-gene-dependent binding and bound significantly stronger to saliva from A, B, and AB than from O individuals (P < 0.0001 and P < 0.001) but did not bind to any samples from secretor-negative individuals. |
| T3 |
343-584 |
Sentence |
denotes |
The two VLPs showed a typical secretor-gene-dependent binding and bound significantly stronger to saliva from A, B, and AB than from O individuals (P < 0.0001 and P < 0.001) but did not bind to any samples from secretor-negative individuals. |
| TextSentencer_T4 |
585-714 |
Sentence |
denotes |
The GII.3 strain showed larger interindividual variation and bound stronger to saliva from B than from A(2) secretors (P < 0.01). |
| T4 |
585-714 |
Sentence |
denotes |
The GII.3 strain showed larger interindividual variation and bound stronger to saliva from B than from A(2) secretors (P < 0.01). |
| T4 |
585-714 |
Sentence |
denotes |
The GII.3 strain showed larger interindividual variation and bound stronger to saliva from B than from A(2) secretors (P < 0.01). |
| TextSentencer_T5 |
715-843 |
Sentence |
denotes |
When assaying for binding to neoglycoproteins, the GII.3 and GII.4 strains were compared with the Norwalk GI.1 prototype strain. |
| T5 |
715-843 |
Sentence |
denotes |
When assaying for binding to neoglycoproteins, the GII.3 and GII.4 strains were compared with the Norwalk GI.1 prototype strain. |
| T5 |
715-843 |
Sentence |
denotes |
When assaying for binding to neoglycoproteins, the GII.3 and GII.4 strains were compared with the Norwalk GI.1 prototype strain. |
| TextSentencer_T6 |
844-998 |
Sentence |
denotes |
Although all three strains bound to Lewis b (and H type 1 chain) glycoconjugates, only the two GII strains showed an additional binding to sialyl Lewis x. |
| T6 |
844-998 |
Sentence |
denotes |
Although all three strains bound to Lewis b (and H type 1 chain) glycoconjugates, only the two GII strains showed an additional binding to sialyl Lewis x. |
| T6 |
844-998 |
Sentence |
denotes |
Although all three strains bound to Lewis b (and H type 1 chain) glycoconjugates, only the two GII strains showed an additional binding to sialyl Lewis x. |
| TextSentencer_T7 |
999-1199 |
Sentence |
denotes |
This novel binding was specific since the VLPs did not bind to structural analogs, e.g., Lewis x or sialyl Lewis a, but only to sialyl Lewis x, sialyl diLewis x and sialylated type 2 chain conjugates. |
| T7 |
999-1199 |
Sentence |
denotes |
This novel binding was specific since the VLPs did not bind to structural analogs, e.g., Lewis x or sialyl Lewis a, but only to sialyl Lewis x, sialyl diLewis x and sialylated type 2 chain conjugates. |
| T7 |
999-1199 |
Sentence |
denotes |
This novel binding was specific since the VLPs did not bind to structural analogs, e.g., Lewis x or sialyl Lewis a, but only to sialyl Lewis x, sialyl diLewis x and sialylated type 2 chain conjugates. |
| TextSentencer_T8 |
1200-1286 |
Sentence |
denotes |
In inhibition experiments, the sialyl Lewis x conjugate was the most potent inhibitor. |
| T8 |
1200-1286 |
Sentence |
denotes |
In inhibition experiments, the sialyl Lewis x conjugate was the most potent inhibitor. |
| T8 |
1200-1286 |
Sentence |
denotes |
In inhibition experiments, the sialyl Lewis x conjugate was the most potent inhibitor. |
| TextSentencer_T9 |
1287-1462 |
Sentence |
denotes |
The minimal requirement for this potential receptor structure is Neu5Ac alpha 3Gal beta 4(Fuc alpha 3)GlcNAc beta 3Gal beta- where Fuc is not absolutely necessary for binding. |
| T9 |
1287-1462 |
Sentence |
denotes |
The minimal requirement for this potential receptor structure is Neu5Ac alpha 3Gal beta 4(Fuc alpha 3)GlcNAc beta 3Gal beta- where Fuc is not absolutely necessary for binding. |
| T9 |
1287-1462 |
Sentence |
denotes |
The minimal requirement for this potential receptor structure is Neu5Ac alpha 3Gal beta 4(Fuc alpha 3)GlcNAc beta 3Gal beta- where Fuc is not absolutely necessary for binding. |
| TextSentencer_T10 |
1463-1731 |
Sentence |
denotes |
Our study shows that some human norovirus GII strains have at least two binding specificities: one secretor-gene-dependent related to alpha1,2-fucosylated carbohydrates and another related to alpha2,3-sialylated carbohydrates of the type 2 chain, e.g., sialyl Lewis x. |
| T10 |
1463-1731 |
Sentence |
denotes |
Our study shows that some human norovirus GII strains have at least two binding specificities: one secretor-gene-dependent related to alpha1,2-fucosylated carbohydrates and another related to alpha2,3-sialylated carbohydrates of the type 2 chain, e.g., sialyl Lewis x. |
| T10 |
1463-1731 |
Sentence |
denotes |
Our study shows that some human norovirus GII strains have at least two binding specificities: one secretor-gene-dependent related to alpha1,2-fucosylated carbohydrates and another related to alpha2,3-sialylated carbohydrates of the type 2 chain, e.g., sialyl Lewis x. |